Blog Read the latest perspectives from our team of subject matter experts and others Ribbon Health and H1: Merging Missions to Transform HealthcareOn January 8th, we celebrated an exciting milestone: Ribbon Health merged with H1! This union represents a significant leap toward achieving our shared vision of transforming healthcare by ensuring… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Diversity & Inclusion Drug Development Global Impact HCP Volunteers KOL Engagement Provider Data Research Post Industries:Commercialization Global Impact Payors Pharmaceutical & Biotechnology Provider Data Research CommercializationHow to Estimate Market Opportunity When Launching New MedTech ProductsImagine your team has been iterating on an innovative idea for a new MedTech device. So how do you decide if commercializing that product will result in ROI for your… Continue reading → Read the article Drug DevelopmentKOL EngagementThe Roles of KOLs in the Drug Development ProcessKey opinion leaders (KOLs) play an important role throughout the entire drug development and approval process. Most companies work with KOLs during Phases IIIa and IIIb as well as during… Continue reading → Read the article KOL EngagementOpinion Leader Identification: Big Data to KOL Short ListFor a pharmaceutical company, the decision to work with a certain key opinion leader (KOL) is very important. Engaging the right KOL is critical in establishing credibility among physicians… Continue reading → Read the article CommercializationThe Dos & Don’ts of Healthcare DatasetsWhere will you find your next MedTech sales opportunity? Healthcare datasets can be great tools for identifying prime prospects in your market. Leveraging healthcare datasets to market your MedTech systems,… Continue reading → Read the article CommercializationSales Associations & Networking Groups for MedTech ProfessionalsMedTech salespeople are understandably so focused on their day-to-day sales activities and quotas that they often miss opportunities to improve their knowledge, skills, and networking opportunities. The most proactive MedTech… Continue reading → Read the article KOL EngagementThe Science of Building and Maintaining a KOL DatabaseA lot has been written about KOLs and the value they can bring not only to drug development and commercialization in the pharmaceutical industry but also to companies developing medical… Continue reading → Read the article«‹1617181920›
